Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study

NCT04016181 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.

NCT NCT04016181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04016181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study
Lead sponsor
University of Edinburgh
Phase
Observational
Overall status
Enrolling by invitation
Start date
June 14, 2007
Completion date
December 1, 2036
Enrollment
800 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asbestosis, idiopathic pulmonary fibrosis, interstitial lung disease